Skip to content

Surgical use of 3D printed cages as adittion for the filling of large bone defects, a randomised controlled trial

Surgical use of 3D printed cages as adittion for the filling of large bone defects, a randomised controlled trial - SCAFFOLD trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56816
Enrollment
26
Registered
2024-06-12
Start date
2024-06-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical size bone defect fracture

Interventions

The control group will receive the standard treatment for these defects in our center. This treatment consists of a two-stage surgical procedure called the Induced Membrane Technique (IMT). During t
a physiological response to the implanted foreign body (the cement spacer). If deemed necessary, soft tissue coverage via free flap transfer is performed as well. In the second stage, the spacer is

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Posttraumatic critical size bone defect of 5 or more centimeters of a long bone after debridement Age over 18 years Informed consent for surgical treatment and participation in the study

Exclusion criteria

Exclusion criteria: Segmental bone defects

Design outcomes

Primary

MeasureTime frame
Follow-up is scheduled at regular intervals; six weeks, twelve weeks, six months, and one year. The primary study endpoint is the volume of newly formed bone at the defect site, based on CT-scans at six months follow-up.

Secondary

MeasureTime frame
Secondary outcome parameters are secondary interventions, quality of life (EQ-5D5L, PROMIS), lower extremity function scale or disabilities of the arm, shoulder and hand (DASH) questionnaire if applicable, necessary reinterventions, recurrence/persistence of infection, burden-of-disease and cost-effectiveness, including the Medical Consumption Questionnaires (MCQ) and Productivity Cost Questionnaire (PCQ).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)